INVITRO GENETICS LIMITED
Get an alert when INVITRO GENETICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£695k
+31.3% vs 2024
Net assets
£2.2m
+647.3% highest in 5 filed years
Employees
24
-11.1% vs 2024
Profit before tax
£2.5m
+546.4% highest in 5 filed years
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-10-31
| Metric | Trend | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2024-10-31 | 2025-10-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | £3,799,266 | £5,523,656 | £5,731,802 | £7,471,051 | £8,953,685 | +19.8% | |
| Operating profit | -£3,569,858 | £226,235 | -£326,955 | £416,576 | £2,509,649 | +502.4% | |
| Profit before tax | -£3,584,527 | £196,915 | -£348,316 | £387,579 | £2,505,403 | +546.4% | |
| Net profit | -£3,359,976 | £68,691 | -£240,200 | £277,773 | £1,869,698 | +573.1% | |
| Cash | £709,517 | £1,134,841 | £479,442 | £529,838 | £695,477 | +31.3% | |
| Total assets less current liabilities | £477,099 | £572,612 | £317,179 | £288,836 | £2,274,175 | +687.4% | |
| Net assets | £461,691 | £530,382 | £290,182 | £288,836 | £2,158,534 | +647.3% | |
| Equity | £461,691 | £530,382 | £290,182 | £288,836 | £2,158,534 | +647.3% | |
| Average employees | 24 | 25 | 27 | 27 | 24 | -11.1% | |
| Wages | £1,583,868 | £1,753,796 | £1,635,800 | £2,004,553 | £2,077,632 | +3.6% | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2024-10-31 | 2025-10-31 |
|---|---|---|---|---|---|---|
| Operating margin | -94.0% | 4.1% | -5.7% | 5.6% | 28.0% | |
| Net margin | -88.4% | 1.2% | -4.2% | 3.7% | 20.9% | |
| Return on capital employed | -748.2% | 39.5% | -103.1% | 144.2% | 110.4% | |
| Current ratio | — | — | — | 0.81x | 1.41x | |
| Interest cover | — | 7.72x | -15.31x | 14.37x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PKF Francis Clark
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate. In forming this view, the directors have considered the future cashflow position of the company and assessed the company's ability to continue to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements (the "going concern assessment period").”
Significant events
- “The Financial Reporting Council has published changes to FRS 102 which will take effect in financial statements for periods ending 31 October 2027. The main rule changes are to revenue and leases.”
- “The company is a member of The Cooper Companies Group which is expected to be a multinational enterprise within the scope of Pillar Two from the 1 November 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ANDREWS, Brian George | Director | 2018-08-08 | May 1978 | American |
| PENFOLD, Nigel Anton | Director | 2025-02-05 | Sep 1972 | British |
| RICUPATI, Agostino | Director | 2017-10-02 | Jan 1967 | American |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AUERBACH, Robert Dave | Director | 2015-12-14 | 2018-08-08 |
| BLAIR, Kerry Lee | Director | 2017-04-26 | 2018-08-08 |
| CALCAGNO, John Joseph | Director | 2019-03-15 | 2025-02-05 |
| GOLDEN, Randal Louis | Director | 2018-08-08 | 2020-04-30 |
| HANSEN, David Truels | Director | 2017-04-18 | 2021-03-30 |
| HVIDKJAER, Jeannett | Director | 2017-04-18 | 2018-05-16 |
| III, Albert George White | Director | 2017-01-31 | 2017-10-02 |
| KAUFMAN, Carol Rose | Director | 2015-12-03 | 2018-08-08 |
| MATZ, Gregory Wayne | Director | 2015-12-03 | 2017-01-31 |
| TUCKER, Alan Thompson | Director | 2018-08-08 | 2019-03-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Coopersurgical Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 59 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-04 | AP01 | officers | Appoint person director company with name date | |
| 2026-08-04 | TM01 | officers | Termination director company with name termination date | |
| 2026-07-30 | AA | accounts | Accounts with accounts type full | |
| 2026-07-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-06-18 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-01 | AA | accounts | Accounts with accounts type full | |
| 2025-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-01 | CH01 | officers | Change person director company with change date | |
| 2025-03-18 | CH01 | officers | Change person director company with change date | |
| 2025-02-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-05 | AA | accounts | Accounts with accounts type full | |
| 2024-07-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-30 | AA | accounts | Accounts with accounts type full | |
| 2023-07-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-27 | AA | accounts | Accounts with accounts type full | |
| 2022-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-27 | AA | accounts | Accounts with accounts type full | |
| 2021-07-08 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-04-06 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.